173 related articles for article (PubMed ID: 27580493)
1. Risk of Extrapyramidal Adverse Events With Aripiprazole.
Etminan M; Procyshyn RM; Samii A; Carleton BC
J Clin Psychopharmacol; 2016 Oct; 36(5):472-4. PubMed ID: 27580493
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis.
Bernagie C; Danckaerts M; Wampers M; De Hert M
CNS Drugs; 2016 Sep; 30(9):807-18. PubMed ID: 27395403
[TBL] [Abstract][Full Text] [Related]
3. Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder.
Gentile S
J Clin Psychopharmacol; 2007 Feb; 27(1):35-45. PubMed ID: 17224710
[TBL] [Abstract][Full Text] [Related]
4. National prescribing patterns in the management of extrapyramidal symptoms among patients with schizophrenia.
Luo RD; Belleti DA; Tran D; Arcona S; Salen PN
Int J Psychiatry Med; 2002; 32(3):261-9. PubMed ID: 12489701
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Expression Profile of Extrapyramidal Symptoms Due to Antipsychotics by Data Mining of Japanese Adverse Drug Event Report (JADER) Database.
Kose E; Uno K; Hayashi H
Yakugaku Zasshi; 2017; 137(1):111-120. PubMed ID: 28049887
[TBL] [Abstract][Full Text] [Related]
6. Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
Etminan M; Sodhi M; Samii A; Procyshyn RM; Guo M; Carleton BC
J Clin Psychopharmacol; 2017 Feb; 37(1):102-104. PubMed ID: 27930495
[TBL] [Abstract][Full Text] [Related]
7. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
[TBL] [Abstract][Full Text] [Related]
8. Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Guo MY; Etminan M; Procyshyn RM; Kim DD; Samii A; Kezouh A; Carleton BC
J Clin Psychopharmacol; 2018 Aug; 38(4):349-356. PubMed ID: 29901567
[TBL] [Abstract][Full Text] [Related]
9. Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Brahm NC; McElwain DL; Brown RC
Am J Health Syst Pharm; 2007 Apr; 64(8):827-9. PubMed ID: 17420198
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
Murphy JE; Stewart RB
Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
[TBL] [Abstract][Full Text] [Related]
11. Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
Tenback DE; van Harten PN; Slooff CJ; van Os J
Am J Psychiatry; 2006 Aug; 163(8):1438-40. PubMed ID: 16877660
[TBL] [Abstract][Full Text] [Related]
12. Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
Selfani K; Soland VL; Chouinard S; Huot P
Neurologist; 2017 Jan; 22(1):24-28. PubMed ID: 28009769
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of antipsychotic drug-induced movement disorders.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole-induced rabbit syndrome: a case report.
Caykoylu A; Ekinci O; Kuloglu M; Deniz O
J Psychopharmacol; 2010 Mar; 24(3):429-31. PubMed ID: 18957477
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
[TBL] [Abstract][Full Text] [Related]
16. Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia.
Tenback DE; van Harten PN; Slooff CJ; van Os J
J Psychopharmacol; 2010 Jul; 24(7):1031-5. PubMed ID: 19487321
[TBL] [Abstract][Full Text] [Related]
17. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1.
Preskorn S; Flynn A; Macaluso M
J Psychiatr Pract; 2015 Sep; 21(5):359-69. PubMed ID: 26348804
[TBL] [Abstract][Full Text] [Related]
18. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
Novick D; Haro JM; Bertsch J; Haddad PM
J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control study.
Schillevoort I; Herings RM; Hugenholtz GW; de Boer A; Nolen WA; Roos RA; Leufkens HG
Pharm World Sci; 2005 Aug; 27(4):285-9. PubMed ID: 16228625
[TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia in older patients.
Jeste DV
J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
